Histogenesis of Kaposi's sarcoma: what is its origin? (Meeting abstract). NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Histogenesis of Kaposi's sarcoma: what is its origin? (Meeting abstract).

Melanoma Res; 3:32-3 1993. Unique Identifier : AIDSLINE ICDB/95607277
Orfanos CE; Wille S; Department of Dermatology, University Medical Center of Steglitz,; The Free University of Berlin, Berlin, Germany


Abstract: Kaposi's sarcoma in HIV-infected individuals develops multicentrically, arising from cells of microvascular origin. Histologically, the tumor lesions express varying levels of differentiation, showing partly incomplete vascular lumina with endothelial cell (EC) proliferation, filled with erythrocytes, mostly surrounded by an inflammatory lymphocytic infiltrate. On the other hand, nodular KS lesions develop in late stages of tumor dissemination composed of spindle-like cells, with or without atypia. Electron microscopic evaluation revealed proliferating cells with ultrastructural features suggesting endothelial origin, but in addition, pericyte-like cells were found. Immunohistochemical investigations with EC-specific antigens (factor VIII-related antigen, BMA-120, EN-4, PAL-E, 1F10, Ulex europaeus ao), endothelial-cell-associated adhesion molecules (ICAM-1, VCAM-1, ELAM-1, PECAM-1, GMP-140) and other antigens (S-100, CD16, HLA-DR, MAC 387) revealed that cells of dermal microvascular walls are proliferating in KS, most likely deriving both from blood and lymph vessels. F VIIIrAg, EN-4, 1F-10 and A10-33/1 showed some differences between endothelium-like cells and spindle cells in KS, after semiquantitative evaluation. Also, staining with PAL-E was lacking in some cases. ICAM-1 and ELAM-1 were clearly less expressed in KS infiltrates than in normal vessels; also, varying VCAM-1 and PECAM-1 expression was found. HLA-DR expression was definitely present in all types of KS lesions. These findings indicate that important endothelial markers are present in KS cells but they appear less expressed in late KS lesions with nodular spindle cell infiltration. Overall, the cellular immunophenotype of the tumor is inconsistent, possibly representing varying cell populations from blood and lymph vessels or varying levels of malignant transformation.
Keywords: Antigens, Surface/IMMUNOLOGY/*METABOLISM Cell Adhesion Molecules/IMMUNOLOGY/*METABOLISM Human Immunohistochemistry Immunophenotyping Microscopy, Electron Sarcoma, Kaposi's/IMMUNOLOGY/*PATHOLOGY/ULTRASTRUCTURE ABSTRACTKWDantigens,surface/immunology/KWDmetabolismcelladhesionmolecules/immunology/KWDmetabolismhumanimmunohistochemistryimmunophenotypingmicroscopy,electronsarcoma,kaposi's/immunology/KWDpathology/ultrastructureabstract
950630
M9561166

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .